藥物成份

共有 21645 個藥物成份

Quetiapine Hemifumarate contains not less than 98.0% and not more than 102.0% of C42H50N6O4S2‧C4H4O4, calculated on the anhydrous basis.

關聯藥證數量
1

Quetiapine fumarate (C46H54N6O8S2): 99.0% to 101.0% (dried substance) Fumaric Acid (C4H4O4): 12.5% to 13.8% (dried substance)

關聯藥證數量
1

Quinupristin/dalfopristin：0.002-32 μg/mL

關聯藥證數量
1

R Test\n\nPIPESa buffer 225 75 mmol/L\nMg2+ 10 3.3 mmol/L\nSodium cholate 0.6 0.2 mmol/L\n4-Aminoantipyrine ³0.45 0.15 mmol/L\nPhenol ³12.6 4.2 mmol/L\nFatty alcohol polyglycol 3 1 %\nEther\nCE ³25 ³8.3 μkat/L (³0.5 kU/L)\nCHOD ³7.5 ³2.5 μkat/L (³0.15 kU/L)\nPOD ³12.5 ³4.1 μkat/L (³0.25 kU/L)\nPH 6.8 6.8\na) PIPES=Piperazine-1,4bis(2-ethanesulfonic acid)

關聯藥證數量
1

R 瓶 A 中的單一試劑(液狀) R Pyrogallol red 50 μmol/L Sodium molybdate 40 μmol/L pH 2.5 Test Pyrogallol red 44 μmol/L Test Sodium molybdate 35 μmol/L pH 2.5 此試劑中含非反應成分緩衝液，清潔劑及安定劑

關聯藥證數量
1

R- I Ammonium Ferrous Sulfate Solution\n Sodium Citrate\n Ammonium Ferrous Sulfate

關聯藥證數量
1

R- II Color Reagent\n 2-Nitroso-5- (N-Propy-N-Sulfopropyl amino ) -phenol ≧0.96mmol/L

關聯藥證數量
1

R-1 : Sodium -HSDA\nR-2 : Cholesterol esterase \n Cholesterol oxidase \n Peroxidase\n 4-aminoantipyrine (4-AA)\n Surfactant\nHDL-C/LDL-C standard : Human serum

關聯藥證數量
1

R-1 Stabilizing Solution\n Tris buffer\nR-2 Latex Solution\n Latex coated with anti-AFP polyclonal antibody 80μ/per test

關聯藥證數量
1

R-1 agent A\nN-(2-hydroxy-3-sulfopropyl)-3.5-Dimethoxyaniline、Peroxidase (From horseradish)、\nR-2 agent B\nUricase、\n4-Aminoantipyrine

關聯藥證數量
1

R-1: Dihydronicotinamide 0.26 mmol/L\n NaCl 255 mmol/L\nR-2: Pyruvate 8.2 mmol/L\n Tris-(hydroxypropyl methyl)-amino methane 408 mmol/L

關聯藥證數量
1

R-1: Enzyme reagent 1: β-NADPH 113 μg/ml\n Buffer solution: α-ketoglutarate 10 mmol/L\nR-2: Enzyme reagent 2: glutamate dehydrogenase 150 IU/mL \n

關聯藥證數量
1

R-1: Glycerol Kinase\n L-α-Glycerorin acid oxydase\n Ascolpin acid oxydase\n Peroxydase \n Adenosin-5\n N-Ethyl-N-Sulhomprobil-m-Torijin\n Magnesium chloride\n Good buffer\nR-2: Lipo protin li pase\n 4-amino anpyrin \n Magnesium chloride\n good buffer \n

關聯藥證數量
1

R-1\nGLDH 2.0 x 104 U/L\nNADPH 0.34 mmol/L\nα-Ketoglutnamqte 6.3 mmol/L \nTroethanolamine 50 mmol/L\nR-2\nUrease 1.4 x 103 U/L \nTroethanolamine 100 mmol/L \n

關聯藥證數量
1

R-1：1.L-Aspartic acid 2.Nicotinamide adeninedinucleotide phosphate (NADH) 3.Malate dehydrogenase (MDH)\nR-2：1.L-Aspartic acid 2.α-ketoglutaric acid

關聯藥證數量
1

R-1：Thymol 13 mmol/L Veronal Buffer pH7.5

關聯藥證數量
1

R-GLUTAMYL-P-NITROANILINE..........4.4MMOL/L GLYCYLGLYCINE.............................150MMOL/L

關聯藥證數量
1

R-I Buffer (#843060): 80 mL x 4\nBuffer\nR-II Color presenting solution (#843070): 40 mL x 4\no-Creswol peptide coordination agent >= 0.12 mmol/L\n8-Hydroxyl quinoline >=17.22 mmol/L

關聯藥證數量
1

R-I Buffer:\nDiethanolamine\nR-II Substrate solution: \nSodium p-nitrophenyl phosphate >51.19mmol/l

關聯藥證數量
1

R-I Color Reagent A\n N-ethyl-(hydroxy-3-sulfopropy)-m-toluidine Na Toos≧1.83 mmol/L\nR-II Color Reagent B\n Uricase (from Yeast) ≧48 U/L\n 4-aminoantipyrine ≧1.18 mmol/L\n Peroxidase(from Horscradish)≧130U/L

關聯藥證數量
1

R-I Enzyme antibody reagent: YAGI anti-HITO CK-M assistance component polychlonal antibody 28 U/L, adenosinediphosphate 2 mmol/L, glucose 10 mmol/L, hexokinase 2000 U/L, nicotinamide adenine dinucleotide phosphate 2.5 mmol/L, glucose-6-phosphate dehydrogenase 1000 U/L; R-II Substrate solution: phosphocreatine-disodium 153 mmol/L, adenosinediphosphate 2 mmol/L, glucose 60 mmol/L.

關聯藥證數量
1

R-I Enzyme assistant enzyme reagent Hexokinase (comes from Yeast) ≧62U/dL Nicotinamide adenine dinucleotide phosphate (oxidative from) ≧1.31 mmol/L Glucose-6-phosphate dehydrogenase (comes from Brcillys ap.) ≧50U/dLR-II Coenzymke reagentSodium adenosinetriphosphate (ATP) ≧ 3.14 mmol/L

關聯藥證數量
1

R-I Enzyme reagent: hexokinase 2000 U/L, nicotinamide adenine dinucleotide phosphate 2.55 mmol/L, glucose-6-phosphate dehydrogenase 1000 U/L, glucose 10 mmol/L; R-II Substrate solution: phosphocreatine-disodium 153 mmol/L, glucose 60 mmol/L.

關聯藥證數量
1

R-I: Coenzyme reagent\nR-II: Substrate solution

關聯藥證數量
1

R-I：Buffer\nR-II：Substrate solution

關聯藥證數量
1

R-I：Coenzyme reagent\nR-II：Substrate solution

關聯藥證數量
1

R-I：L-ascorbic acid；R-II：2-Nitroso 5-(N-propyl-N-sulfopropylamino) phenol 0.45 mmol/L

關聯藥證數量
1

R-I：diluent\nR-II：molybdate ammonium ≧ 1.29 mmol/L

關聯藥證數量
1

R0 Dibucaine 2.57mmol/L in vial A(liquid).R1 DTNB 1.3mmol/L in vial B (granulate). R2=SR S-Butyrylthiocholine iodide 75mmol/L in vial C (granulate)Active IngredientsComponents Concentrations (reconstituted) R0 R1 SR TestDibucaine 2.57 0.1 mmol/LPhosphate 250 50 mmol/L5,5’-dithiobis- 1.3 0.3 mmol/L 2-nitrobenzoate S-Butyrylthiocholine 75 6 mmol/L IodidePH 6.5 7.6 2.6 7.6

關聯藥證數量
1

R1 AMP（buffer）pH10.2 413 mmol/L MgCl2 1.25 mmol/LR2 p-nitrophenylphosphate 32.5 mmol/L

關聯藥證數量
1

R1 AcceleratorPolyethylene glycol (PEG) in phosphate buffer stabilized with 0.09% sodium azide in vial B (liquid).R2=SR Anti-α1-acid glycoprotein T antiserum (rabbit) specific for human α1-acid glycoprotein, in phosphate buffer stabilized with 0.09% sodium azide in vial C (liquid)

關聯藥證數量
1

R1 Nitroblue in vial B (liquid).Nitroblue tetrazolium 1.2 mmol/LUricase (microbial) ≧12μkat/LNonreactiive buffer, stabilizer and surfactants.pH 7.5R2=SR Buffer in vial C (liquid).Carbonate 1.5 mol/LpH 10.4

關聯藥證數量
1

R1 Reaction buffer Glycine buffer:170 mmol/L, pH8.0, polyethylene glycol 0.05%, bovine serum albumin, in vial B (liquid).R2=SR Latex particles coated with human IgG, glcine buffer: 170 mmol/L, pH7.3, in vial C (liquid).

關聯藥證數量
1

R1 TRIS 224 mmol/L L-Alanine 1120 mmol/L LDH (microbial) ≧45 μkat/L(≧1.25kU/L) Albumin (bovine) 0.25 % Sodium azide 0.09 %R2 NADH ≧ 1.7 mmol/L 2-Oxoglutarate 94 mmol/L Sodium azide 0.09 %

關聯藥證數量
1

R1 TRIS\n Polyethylene Glycol\n Sodium Azide\nR2 Anti-human complement C4 goat serum\n TRIS 100\n Sodium Azide\n

關聯藥證數量
1

R1 Antibody reagent in vial A and B (liquid). Anti-T4 monoclonal antibody (mouse).R2=SR Tracer reagent in vial C (liquid). Fluorescein-labeled T4 derivative.

關聯藥證數量
1

R1 Anti-albumin T antiserum (rabbit) specific for human albumin, in phosphate buffer stabilized with 0.09% sodium azide in vial B (liquid).R2 Reagent for antigen excess check (only used for urine application).Albumin in diluted serum (human) stabilized with 0.09% sodium azide in vial C (liquid).

關聯藥證數量
1

R1 Antibody reagent in vial A (liquid). Anti-lidocaine polyclonal antibody (sheep) in buffer, pH 7.5, with stabilizer and preservative.RS=SR Tracer reagent in vial C (liquid). Fluorescein-labeled lidocaine derivative in buffer, pH 6.0, with stabilizer and preservative.

關聯藥證數量
1

R1 Antibody reagent in vial A (liquid).Anti-NAPA monoclonal antibody (mouse) in buffer, pH7.5, with stabilizer and preservative.R2=SR Tracer reagent in vial C (liquid).Fluorescein-labeled NAPA derivative in buffer, pH6.5, with stabilizer, surfactant, and preservative.

關聯藥證數量
1

R1 Antibody reagent in vial A and B (liquid). Anti-valproic acid monoclonal antibody (mouse). R2=SR Tracer reagent in vial C (liquid). Fluorescein-labeled valproic acid derivative.

關聯藥證數量
1

R1 Guanidine hydrochloride in vial A (liquid).R2 Ascorbate in vial B (granulate).R3=SR FerroZine in vial C (liquid).

關聯藥證數量
1

R1 Triethanolamine buffer: 151 mmol/l, pH 8.6; α-Ketoglutarate:16.6 mmol/l; ADP: ≧ 1.2 mmol/l; preservatives.R2 NADPH: ≧ 458 μmol/l; GLDH: ≧ 24.3 U/ml (EC 1.4.1.3; bovine liver; 25°C); Triethanolamine buffer: 151 mmol/l, pH 8.6; α-Ketoglutarate: 16.6 mmol/l; ADP: ≧ 1.2 mmol/l; preservatives.

關聯藥證數量
1

R1 Accelerator Polyethylene glycol (PEG) 50g/L, in phosphate buffer stabilized with 0.09% sodium azide in vial A (liquid). R2=SR Anti-prealbumin T antiserum (rabbit) specific for human Prealbumin > 0.25g/L in phosphate buffer stabilized with 0.09% sodium azide in vial C (liquid).

關聯藥證數量
1

R1 Antibody reagent in vial A (liquid). Anti-amikacin monoclonal antibody (mouse).R2 Diluent in vial B (liquid).R3=SR Tracer reagent in vial C (liquid). Fluorescein-labeled amikacin derivative.

關聯藥證數量
1

R1 Imidazole buffer: 123 mmol/L, pH 6.5 (37 °C); EDTA: 2.46 mmol/L; Mg2+: 12.3 mmol/L; ADP: 2.46 mmol/L; AMP: 6.14 mmol/L; diadenosine pentaphosphate: 19 μmol/L; NADP+ (yeast): 2.46 mmol/L; N-acetylcysteine: 24.6 mmol/L; HK (yeast): ≥ 36.7 μkat/L; G6PDH (E.coli): ≥ 23.4 μkat/L; preservative; stabilizer; additive.\nR3 CAPSO* buffer: 20 mmol/L, pH 8.8 (37 °C); glucose: 120 mmol/L; EDTA: 2.46 mmol/L; creatine phosphate: 184 mmol/L; preservative; stabilizer; additive.\n

關聯藥證數量
1

R1 TRIS buffer: 20 mmol/L, pH 8.0; NaCl: 200 mmol/L; polyethylene glycol: 3.6 %; preservative; stabilizers\n \nR3 Anti-human IgG antibody (goat): dependent on titer; TRIS buffer: 20 mmol/L, pH 8.0; NaCl: 150 mmol/L; preservative\n

關聯藥證數量
1

R1 TRIS buffer: 20 mmol/L, pH 8.0; NaCl: 200 mmol/L; polyethylene glycol:\n 3.6 %; preservative; stabilizers\nR3 Anti-human IgA antibody (goat): dependent on titer; TRIS buffer:\n 20 mmol/L, pH 8.0; NaCl: 150 mmol/L; preservative\n

關聯藥證數量
1

R1 Buffer (phosphate 68 mmol/L, pyruvate 0.73 mmol/L) in vial A and B (liquid).R2=SR Coenzyme (NADH 1.1 mmol/L) in vial C (liquid).

關聯藥證數量
1

R1 Folate binding protein~Ru(bpy)2+3 (gray cap), 1 bottle, 9 mL: Ruthenium labeled folate binding protein 75 μg/L; human serum albumin (stabilizer); borate/phosphate/citrate buffer 70 mmol/L, pH 5.5; preservative.\nR2 Folate~biotin (black cap), 1 bottle, 8 mL: Biotinylated folate 17 μg/L; biotin 120 μg/L; human serum albumin (stabilizer); borate buffer 100 mmol/L, pH 9.0; preservative.

關聯藥證數量
1

R1 Glycine buffer with bovine serum albumin stabilized with 0.09% sodium azide in vial A (liquid). R2=SR Latex particles coated with streptolysin O antigens in glycine buffer with bovine serum albumin, stabilized with 0.09% sodium azide in vial B (liquid).

關聯藥證數量
1

R1 Glycine buffer: 170 mmol/L, pH 8.0; polyethylene glycol: 0.05 %; bovine\n serum albumin; stabilizer; preservative\nR3 Latex particles coated with human IgG; glycine buffer: 170 mmol/L, pH 7.3;\n stabilizer; preservative\n

關聯藥證數量
1

R1 HEPES: 52.4 mmol/L; sodium chloride: 87 mmol/L; calcium chloride:\n 0.08 mmol/L; magnesium chloride: 12.6 mmol/L; α-glucosidase (microbial):\n ≥ 66.8 μkat/L; pH 7.0 (37 °C); preservatives; stabilizers\nR3 HEPES: 52.4 mmol/L; ethylidene-G7-PNP: 22 mmol/L; pH 7.0 (37 °C);\n preservatives; stabilizers\n

關聯藥證數量
1

R1 Phosphate buffer: 12.7 mmol/L, NaCl: 0.13 mol/L; PEG: 40 g/L.R2 Anti-human α1-antitrypsin antibody (rabbit): > 2 g/L; NaCl: 0.12 mol/L.

關聯藥證數量
1

R1 Anti-PCT-Ab~biotin (gray cap), 1 bottle, 9 mL: Biotinylated monoclonal anti-PCT antibody (mouse) 2.0 μg/mL; phosphate buffer 95 mmol/L, pH 7.5; preservative.

關聯藥證數量
1

R1 Antibody reagent in vial A and B (liquid).

關聯藥證數量
1

R1 Antibody reagent in vial A and B (liquid). Anti-phenytoin monoclonal antibody (mouse).R2=SR Tracer reagent in vial C (liquid). Fluorescein-labeled phenytoin derivative.

關聯藥證數量
1

R1 Chlorophosphonazo Ⅲ in vial A and B (liquid).R2=SR EDTA in vial C (liquid).

關聯藥證數量
1

R1 Citric acid:200 mmol/L; thiourea:115 mmol/L; detergentR2 Sodium ascorbate:150 mmol/L; FerroZine:6 mmol/L;preservative

關聯藥證數量
1

R1 Conjugated amphetamine, methamphetamine, and MDMA derivatives;\n buffer; bovine serum albumin; 0.09 % sodium azide\nR2 Microparticles attached to amphetamine, methamphetamine, and\n MDMA antibodies (mouse monoclonal); buffer; bovine serum albumin;\n 0.09 % sodium azide\n

關聯藥證數量
1

R1 Glycylglycine 110 mmol/L\n Tris buffer 130 mmol/L\nR2 r-glutamyl-p-nitroanililde 21 mmol/L\n Citric acid buffer 15 mmol/L

關聯藥證數量
1

R1 Imidazole buffer: 123 mmol/L, pH 6.5 (37°C); EDTA: 2.46 mmol/L;\n Mg2+: 12.3 mmol/L; ADP: 2.46 mmol/L; AMP: 6.14 mmol/L;\n Diadenosine pentaphosphate: 19μmol/L; NADP (yeast): 2.46 mmol/L;\n N-acetylcysteine: 24.6 mmol/L; HK (yeast) ≧ 36.7 μkat/L; G6P-DH (E.coli):\n≧ 23.4 μkat/L.\nR2 CAPSO buffer: 20 mmol/L, pH 8.8 (37°C); glucose: 120 mmol/L;\n EDTA: 2.46 mmol/L; creatine phosphate: 184 mmol/L.\n

關聯藥證數量
1

R1 Phosphate buffer: 200 mmol/L, GOD\n >= 183 ukat/L; POD>= 0.33 ukat/L; 4- aminophenazone:\n0.77 mmol/L; phenol: 11 mmol/L\n

關聯藥證數量
1

R1 Sulfamic acid 70 mmol/L HCl 70 mmol/LR2 3.5-DCPD 5 mmol/L

關聯藥證數量
1

R1 TRIS buffer: 50 mmol/L, pH 8.0; PEG: 4.2 %; EDTA: 2.0 mmol/L; preservative\nR2 Polyclonal anti-human albumin antibodies (sheep): dependent on titer;\n TRIS buffer: 100 mmol/L, pH 7.2; preservative\n Antigen Excess Reagent (for ACN 8253):\nR3 Albumin in diluted serum (human); NaCl: 150 mmol/L; phosphate\n buffer: 50 mmol/L, pH 7.0; preservative\n

關聯藥證數量
1

R1 Tris buffer: ≧ 0.2 mol/l, pH 8.45; Ferrous ammonium sulfate: ≧ 8.4 μmol/l; Hydroxylamine hydrochloride: ≧0.1 mol/l; Nonionic surfactant: thiourea; Dilute sulfuric acidR2 FerroZine: 20.3 mmol/l; Preservative

關聯藥證數量
1

R1 (Bottles 1,1a and 2)\n Citrate buffer: 150 mmol/L, pH 4.8；1-naphthyl phosphate:12.1 mmol/L；fast red TR salt: 1.2mmol/L；1,5-pentanediol:220 mmol/L；3.3mL/L；preservative.(Additionally for non-prostatic acid phosphatase determination: sodium tartrate:100 mmol/L)\n3 Acetic acid: 0.8 mol/L

關聯藥證數量
1

R1 Alkaline buffer in vial B (liquid).

關聯藥證數量
1

R1 Anti-IgM T antiserum (rabbit) specific for human\n IgM in phosphate buffer stabilized with 0.09% sodium azide in vial B (liquid).\n\nR2 Reagent for antigen excess check.\n IgM in diluted serum (human) stabilized with 0.09% sodium azide in vial C (liquid).\n

關聯藥證數量
1

R1 Blank：Sodium hydroxide,EDTA-Na in vial A (liquid)\nR2=SR U/CSF Reagent：Benzethonium chloride in vial C (liquid)

關聯藥證數量
1

R1 Buffer, preservatives

關聯藥證數量
1

R1 Conjugate Reagent Gentamicin conjugate; piperazine-N, N-bis (ethanesulfonic acid) (PIPES) buffer pH 7.2; preservative. \nR2 Latex-Antibody Reagent Anti-gentamicin antibody (mouse monoclonal); latex microparticle; 3-(N-morpholino) propane sulfonic acid (MOPS) buffer pH 7.5; stabilizer; preservative.

關聯藥證數量
1

R1 Conjugate Working Solution\n Conjugated methadone derivative in buffer.\nR2 Antibody/Microparticle Working Soltuion\n Microparticles attached to methadone antibody \n (mouse monoclonal).

關聯藥證數量
1

R1 EA Solution enzyme acceptor (microbial): 0.22 g/l; anti-tobramycin antibody (mouse monoclonal): 25.5 mg/l; 3-(N-morpholino) propanesulfonic acid (MOPS) buffer; buffer salts; surfactant; carrier protein.R2 E D Solutionenzyme donor (microbial)-tobramycin: 23.4 μg/l; chlorophenol red-β-D-galactopyranoside: 2.4 g/l; goat anti-mouse antibodies: 3.3 g/l; 3-(N-morpholino) propanesulfonic acid (MOPS) buffer salts, surfactant

關聯藥證數量
1

R1 H. influenzae type b latex:\nAnti-H. influenzae type b serum (rabbit) (sodium merthiolate 0.2 g/l+sodium azide 1 g/l).\nR2 Streptococcus pneumoniase omhi type latex:\nAnti-S. pneumoniae serum (rabbit) (sodium merthiolate 0.2 g/l+sodium azide 1g/l).\nR3 Neissria meningitides group A latex:\nAnti-N. meningitides A serum (rabbit) (sodium merthiolate 0.2 g/l+sodium azide 1 g/l). \nR4 Neisseria meningitides group B/ Escherichia coli K1 latex:\nAnti-N. meningitides B monoclonal antibody (mouse) (sodium merthiolate 0.2 g/l+sodium azide 1 g/l). \nR5 Neisseria meningitides group C latex:\nAnti-N. meningitides C serum (rabbit) (sodium merthiolate 0.2 g/l+sodium azide 1g/l). \nR6 Positive control: (lyophilized)\nAntigen extracts of H. influenzae b, S.pneumoniae, N.meningitides A, C, E.coli K1 (sodium merthiolate 0.1 g/l). \n

關聯藥證數量
1

R1 HEPES buffer: 10.07 mmol/L; CHES: 96.95 mmol/L; dextran sulfate: 1.5g/L; magnesium nitrate hexahydrate: ≧11.7 mmol/L; HSDA: 0.96 mmol/L; ascorbate oxdase(Eupenicillium sp., recombinant)≧ 50 μkat/L (3.0 kU/L); peroxidase ≧16.7 μkat/L (1.0 kU/L).R2 HEPES buffer: 10.07 mmol/L,pH 7.0 ; PEG-cholesterol esterase (Pseudomonas spec.) ≧3.33 μkat/L(0.2 kU/L); PEG-cholesterol oxidase (Streptomyces sp., recombinant) ≧127 μkat/L (7.6 kU/L); peroxidase(horseradish)≧ 333 μkat/L (20 kU/L); 4-amino-antipyrine:2.46 mmol/LR2 HEPES buffer: 10.07 mmol/l; PEG-cholesterol oxidase > 127 μkat/l (7.6 kU/l); peroxidase > 333 μkat/l (20 kU/l); 4-amino-antipyrine:2.46 mmol/l\n

關聯藥證數量
1

R1 HEPES buffer: 52.5 mmol/L, pH 7 (37˚C); sodium chloride: 87 mmol/L; magnesium chloride: 12.6 mmol/L; calcium chloride: 0.075 mmol/L; α-glucosidase (microorganisma)≧4 kU/L; monoclonal antibodies (mouse): 97 mg/L R2 HEPES buffer: 52.5 mmol/L, pH 7 (37˚C); 4,6-ethylidene-G7PNP; 22 mmol/L

關聯藥證數量
1

R1 HEPES, α-Glucosidase, Mg2+, sodium chloride, and Ethylidene-G7-PNP\nR2=SR HEPES, and Ethylidene-G7-PNP

關聯藥證數量
1

R1 Imidazole buffer: 123 mmol/L, pH 6.5 (37°C); EDTA: 2.46 mmol/L; Mg2+: 12.3 mmol/L; ADP: 2.46 mmol/L; AMP: 6.14 mmol/L; diadenosine pentaphosphate: 19 μmol/L; NADP (yeast): 2.46 mmol/L; N-acetylcysteine: 24.6 mmol/L; HK (yeast): ≧36.7 μkat/L (25°C); G6P-DH (E.coli): ≧23.4 μkat/L (25°C); preservative; stabilizer; additive.\nR2 CAPSO buffer: 20 mmol/L, pH 8.8 (37°C); glucose: 120 mmol/L; Mg2+: 11 mmol/L; EDTA: 2.46 mmol/L; creatine phosphate: 184 mmol/L; 4 monoclonal anti-CK-M antibodies (mouse), inhibiting capacity: >99.6% up to 66.8 μkat/L (4000 U/L) (37°C) CK-M subunit; preservative; stabilizer; additive.

關聯藥證數量
1

R1 MES buffer: 5.0 mmol/L, pH 6.0; Mg2+: 24 mmol/L; ATP: ≥ 4.5 mmol/L;\n NADP: ≥ 7.0 mmol/L; preservative\nR3 HEPES buffer: 200 mmol/L, pH 8.0; Mg2+: 4 mmol/L; HK (yeast):\n ≥ 300 μkat/L; G-6-PDH (E. coli): ≥ 300 μkat/L; preservative\n

關聯藥證數量
1

R1 NaCl 9 %\nR2 TRIS buffer: 220 mmol/L, pH 8.6; 2-oxoglutarate: 73 mmol/L; NADH: 2.5 mmol/L; ADP: 6.5 mmol/L; urease (jack bean): ≥ 300 μkat/L; GLDH (bovine liver): ≥ 80 μkat/L; preservative; nonreactive stabilizers

關聯藥證數量
1

R1 PIPES buffera:50 mmol/l, pH 6.8;Mg2+:40 mmol/l;sodium cholate: 0.20mmol/l;ATP≧1.4 mmol/l;4-aminophenazone≧0.13 mmol/l;4-chlorophenol:4.7 mmol/l; potassium hexacyanoferrate(II):1μmol/l;fatty alchol polyglycol ether: 0.65%;lipoprotein lipase(pseudomonas spec.)≧5.0 U/ml; glycerokinase(Bacillus stearothermophilus)≧0.19 U/ml; Glycerol phosphate oxidase (E. coli)≧2.5 U/ml; peroxidase (horseradish)≧0.10 U/ml; preservative a)PIPES=piperazine-N,N'-bis(2-ethanesulfonic acid)

關聯藥證數量
1

R1 Phosphate buffer: 12.7 mmol/l, pH7.2；NaCl: 0.13 mol/l；PEG: 70 g/l；preservative\nR2 Anti-human ceruloplasmin antibody (rabbit): dependent on titer；NaCl: 0.1 mol/l；preservative

關聯藥證數量
1

R1 Phosphate buffer: 60 mmol/L, pH 7.5; NaCl: 100 mmol/L;polyethylene glycol (PEG): 30g/L; preservative, in vial A (liquid).\nR2 Latex particles coated with polyclonal anti-human Lp(a) antibodies (rabbit); glycine buffer: 25 mmol/L, pH 9.6; preservative, in vial B (liquid).\n

關聯藥證數量
1

R1 Phosphate buffer: 68 mmol/L, pH 7.5; α-ketobutyrate:3.7 mmol/L; preservative

關聯藥證數量
1

R1 Phosphate buffer、NaCl、polyethylene glycol.\nR2 Anti-human transterrin antibodies (rabbit)、NaCl.

關聯藥證數量
1

R1 Pyrophosphate buffer: 92 mmol/L, pH 7.7; potassium hexacyanoferrate (III): 2.4 mmol/L\nR2 GOODs buffer: 10 mmol/L, pH 4.0; butyrylthiocholine: 46 mmol/L; stabilizers.

關聯藥證數量
1

R1 R2 R3Potassium 80 mmol/LHydroxide 900 mmol/LPhosphate 135 12 mmol/LPicric acid 50 4.4 mmol/L

關聯藥證數量
1

R1 Saturating reagent in vial B (liquid). R2=SR FerroZine in vial C (liquid). Active ingredientsComponents Concentrations R1 R2 Test TRIS 375 150 Mmol/LFerrous chloride 62 25 mmol/LSodium hydrogen carbonate 75 30 μmol/LFerroZine 20 2.5 mol/LHydroxylamine 160 20 mol/LSodium azide 0.02 0.01 %PH 8.4 2.5 8.4 Reagent R1 contains a nonreactive stabilizer.

關聯藥證數量
1

R1 Sodium hydroxide: 0.20 mol/l\nR2 Picric acid: 25 mmol/l

關聯藥證數量
1

R1 Sodium hydroxide: 400 mmol/L; potassium sodium tartrate: 89 mmol/L

關聯藥證數量
1

R1 Sulfamic acid 70 mmol/L\n HCl 70 mmol/L\n DMSO 5 mol/L\nR2 3.5-DCPD 5 mmol/L

關聯藥證數量
1

R1 Sulfamic acid (H3NO3S): 110 mmol/L; sodium acetate buffer (C2H3NaO2):\n 85 mmol/L; surfactant; solubilizer\nR3 Diazonium ion: 3 mmol/L; HCl: 100 mmol/L\n

關聯藥證數量
1

R1 TAPS buffer (N-Tris(hydroxymethyl)methyl-3-aminopropanesulfonic acid): 30 mmol/L, pH 8.1;\n creatinase (microorganisms): ≥332 μkat/L; sarcosine oxidase (microorganisms):≥132 μkat/L;\nascorbate oxidase (microorganisms): ≥33 μkat/L; HTIB: 1.2 g/L; detergents; preservative\n \nR3 TAPS buffer: 50 mmol/L, pH 8.0; creatininase (microorganisms): ≥498 μkat/L;\n peroxidase (horseradish): ≥16.6 μkat/L; 4-aminophenazone: 0.5 g/L; potassium\n hexacyanoferrate (II): 60 mg/L; detergent; preservative\n

關聯藥證數量
1

R1 TAPS** buffer: 30 mmol/L, pH 8.1: creatinase (microorganisms) ≧ 333 μkat/L; sarcosine oxidase (microorganisms) ≧ 133 μkat/L; ascorbate oxidase (microorganisms) ≧ 33 μkat/L; HTIB: 5.9 mmol/L; detergents; preservative.R2 TAPS** buffer: 50 mmol/L, pH 8.0; creatininase (microorganisms) ≧ 500 μkat/L; peroxidase (horseradish) ≧ 16.7 μkat/L; 4-aminophenazone: 2.0 mmol/L; potassium hexacyanoferrate (II): 163 μmol/L; detergent; preservative.**TAPS=3-[[tris(hydroxymethyl) methyl] amino] propanesulfonic acid.

關聯藥證數量
1

R1 TRIS buffer: 100 mmol/L, pH 7.8; L-aspartate: 300 mmol/L; NADH (yeast): 0.23 mmol/L; MDH (porcine heart) ≧ 0.53 U/mL (8.83 μkat/L); LDH (microorganisms) ≧0.75 U/mL (12.5 μkat/L); \nR2 α-ketoglutarate: 75 mmol/L.

關聯藥證數量
1

R1 TRIS buffer: 100 mmol/L, pH8.0; polyethylene glycol: 3.0%; in vial B.\nR2 Anti-human C3c antibody (goat): 33 mmol/L in vial C.

關聯藥證數量
1

R1 TRIS buffer: 264 mmol/L, pH 7.8 (37 °C); L-aspartate:\n 792 mmol/L; MDH (microorganism): ≥ 24 μkat/L; LDH\n (microorganisms): ≥ 48 μkat/L; albumin (bovine):\n 0.25 %; preservative\nBottle Pyridoxal phosphate\nR3 = cobas c pack NADH: ≥ 1.7 mmol/L; 2-oxoglutarate: 94 mmol/L\nposition C ;preservative\n

關聯藥證數量
1

R1 TRIS buffer: 400 mmol/L, pH 7.8; L-aspartate: 1200 mmol/L; NADH (yeast): 0.91 mmol/L; MDH (porcine hear) ≧ 2.1 U/mL (35 μkat/L); LDH (microorganisms) ≧3.0 U/mL (50 μkat/L); preservative.\nR2 α-Ketoglutarate: 75 mmol/L; preservative.

關聯藥證數量
1

R1 TRIS buffer: 50 mmol/L, pH 8.0; PEG: 4.2%; detergent; preservative.\nR2 Anti-human apolipoprotein B antibodies (sheep): dependent on titer; TRIS buffer: 100 mmol/L, pH 8.0: preservative.

關聯藥證數量
1

R1 TRIS buffera: 100 mmol/L, polyethylene glycol: 3.0%\nR2 Anti-human C4 antibody dependent on titer; TRIS buffer: 33 mmol/L

關聯藥證數量
1